🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To seek the efficacy signals of trastuzumab in combination with chemotherap...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-07-01
Trial ID
NCT03185988
We want to compare Taxol given weekly with Taxotere given every 3 week both...
Status
Completed
Location
Ullevål university hospital
Start Date
2005-03
Trial ID
NCT00201435
This 2 arm study compared the efficacy and safety of label dose of capecita...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00077857
Treatments Being Tested
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
The study is designed to test the hypothesis that patients with Locally adv...
Status
Active Not Recruiting
Location
University of California, Irvine
Start Date
2013-11
Trial ID
NCT02008656
RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in differ...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2003-12
Trial ID
NCT00258310
Treatments Being Tested
The fluoropyrimidines 5-fluorouracil (5FU) and capecitabine (Cp) are among ...
Status
Completed
Location
Inselspital
Start Date
2012-10
Trial ID
NCT01641458
RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in differ...
Status
Terminated
Location
CCOP - Wichita
Start Date
2005-09
Trial ID
NCT00227656
Treatments Being Tested
Researchers are looking for new ways to treat types of breast cancer that a...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0066)
Start Date
2025-06-30
Trial ID
NCT06966700
The purpose of this study is to investigate whether endostar (recombinant h...
Status
Completed
Location
Department of GI Oncology, Peking University, School of Oncology
Start Date
2008-11
Trial ID
NCT00842491
Treatments Being Tested